Search Results By Year:
Showing 226 - 240 of 265 results
  • Adams EM, Gudmundsson S, Yocum DE, Haselby RC, Craig WA, Sundstrom WR. Streptococcal myositis. Arch Intern Med. 1985 Jun;145(6):1020-1023.
    PubMed ID: 3890787
  • Motszko CS, Marx JJ, Haselby RC, Kettrick MAlice, Baldauf MC, Mitchell PD. A randomized trial of transfer factor therapy in the treatment of herpes zoster infections. Immunology & Allergy Practice. 1985 Jan;7(1):37-42.
  • McKiernan FE, Cowdery JS. Enteric immunization with a soluble protein antigen induces antigen specific B-cells in Peyer's patches. Fed Proc. 1985;44(5):1714.
  • Hines JD, Mazza JJ, Oken MM, Bennett JM, Adelstein DJ, Keller AM, O'Connell MJ. High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology Group. Semin Oncol. 1985 Jun;12(2 Suppl 3):117-119.
    PubMed ID: 3839318
  • Spiers AS, Davis MP, Levine M, Mangan KF, Mazza JJ, Neu LT, O'Brien J, Rauch AE, Wiltsie JC. T-cell chronic lymphocytic leukaemia: anomalous cell markers, variable morphology, and marked responsiveness to pentostatin (2'-deoxycoformycin). Scand J Haematol. 1985 Jun;34(1):57-67.
    PubMed ID: 2578689
  • Mazza JJ. Chronic lymphocytic leukemia..
  • Mazza JJ. Chronic myelogenous leukemia..
  • Hines JD, Mazza JJ, Oken MM, Keller AM, Adelstein DJ, Bennett JM, O'Connell MJ. High dose Ara-C and mAMSA in the treatment of relapse and refractory acute nonlymphocytic leukemia (ANLL). Proc Am Soc Oncol. 1984;3 :189.
  • Cassileth PA, Begg CB, Bennett JM, Burkart P, Keller AM, Knospe W, Mazza JJ, Scharfman W, Spiers AS, Weiler C, O'Connell MJ. Intensive consolidation therapy with high dose cytosine arabinoside (Ara-C) and amsacrine (AMSA) in adults with acute nonlymphocytic leukemia (ANLL). Proc Am Soc Clin Oncol. 1984;3 :194.
  • Hines JD, Oken MM, Mazza JJ, Keller AM, Streeter RR, Glick JH. High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia. J Clin Oncol. 1984 Jun;2(6):545-549.
    PubMed ID: 6233399
  • Friedenberg WR, Gatlin PF, Mazza JJ, Beltaos E, Hoehn JL, Pierce WE, Gehlsen JA, Schloesser LL. Prognostic value of serum lactic dehydrogenase level in Hodgkin's disease. J Lab Clin Med. 1984 Mar;103(3):489-490.
    PubMed ID: 6699469
  • Kahn SB, Begg CB, Mazza JJ, Bennett JM, Bonner H, Glick JH. Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly. J Clin Oncol. 1984 Aug;2(8):865-870.
    PubMed ID: 6379120
  • Conterato JP, Friedenberg WR, Mazza JJ, Gatlin PF, Gehlsen JA, Schloesser LL. Improved treatment of acute nonlymphocytic leukemia in a community hospital. The Marshfield Clinic/St. Joseph's Hospital experience 1974-1981. Proc Am Soc Clin Oncol. 1983;2 :171.
  • Hines JD, Oken MM, Mazza JJ, Keller AM, Streeter RR. High dose cytosine arabinoside (Ara-C) and mAMSA in relapsed acute nonlymphocytic leukemia (ANLL). Proc Am Soc Clin Oncol. 1983;2 :173.
  • Kahn SB, Begg CB, Mazza JJ, Glick JH. Full dose daunorubicin (D), cytosine arabinoside (A) and thioguanine (T) (F-DAT) versus attenuated DAT (AT-DAT) in the treatment of ANLL in the elderly. Results of a randomized ECOG trial. Proc Am Soc Clin Oncol. 1983;2 :178.